Zotefoams plcLSE: ZTF

Zotefoams: Notification of Transactions of Directors/PDMRs

· Issued by Zotefoams plc via RNS

Summary by 6ix AI

Jack Clarke, a non-executive director of foam maker Zotefoams plc, bought 4,290 ordinary shares of 5 pence each in the company on November 9, 2026, at a price of £4.6363 per share.

Key details

  • After the purchase, Jack Clarke is beneficially interested in 4,290 ordinary shares, approximately 0.01% of Zotefoams' issued share capital.
  • The purchase was a single transaction carried out on the London Stock Exchange (venue code XLON).
  • The disclosure is made under Article 19 of the UK Market Abuse Regulation, which requires directors and senior managers to report their dealings in company shares.

6ix AI wrote this summary from the release below and checked it against the release.

Zotefoams PLC
10 November 2026

Zotefoams plc

(the ‘Company’)

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMR

10 November 2026

The Company has received notification that on 9 November 2026 Jack Clarke, Non-Executive Director of the Company, purchased 4,290 ordinary shares of 5 pence each in the Company at a price of £4.6363 per share.

Following this transaction, Jack is beneficially interested in 4,290 ordinary shares in the Company, representing approximately 0.01% of the Company's issued share capital.

The Dealing Notification Form can be found below.

This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Enquiries:

Zotefoams plc

IFC Advisory (Financial PR & IR)

Ronan Cox, Group CEO

Nick Wright, Group CFO

+44 (0) 208 664 1600

Graham Herring

Tim Metcalfe

Zach Cohen

+44 (0) 203 934 6630

About Zotefoams plc

Zotefoams plc (LSE: ZTF) is a world leader in high-performance foam technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets.

Zotefoams is headquartered in London, UK, with foam manufacturing sites in Croydon, UK; Kentucky and Pennsylvania, USA; Brzeg, Poland; Anglesola and Burgos, Spain; and Vietnam. The Group also manufactures and converts foam products in Oklahoma, USA, and manufactures T-FIT® advanced insulation in Jiangsu Province, China.

AZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com

NOTIFICATION OF DEALING FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Jack Clarke

2. Reason for the notification

a) Position / status

Non-Executive Director

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Zotefoams plc

b) LEI

213800B6P256B5XN8D32

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each

Identification code: GB0009896605

b) Nature of the transaction

Purchase of ordinary shares

c) Price(s) and volume(s)

Price(s)

Volume(s)

£4.6363

4,290

d) Aggregated information

n/a - single transaction

e) Date of the transaction

9 November 2026

f) Place of the transaction

XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Zotefoams plc on 6ix

Story so far

Earlier from Zotefoams

All Zotefoams news releases